ShangPharma Corporation , NYSE: SHP
Second-largest Chinese pharmaceutical/biotechnology R&D outsourcing firm.
Industry: Health Care
First Day Return: -15.0%
Industry: Health Care
| IPO Data | |
|---|---|
| IPO File Date | 09/30/2010 |
| Offer Price | $15.00 |
| Price Range $14.50 - $16.50 | |
| Offer Shares (mm) | 5.8 |
| Deal Size ($mm) | $87 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 10/18/2010 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $87 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Shanghai, China |
| Founded | 2002 |
| Employees at IPO | n/a |
| Website www.shangpharma.com | |
ShangPharma Corporation (SHP) Performance
